ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,627, issued on March 24, was assigned to SOCIETE DES PRODUITS NESTLE S.A. (Vevey, Switzerland) and SOCPRA SCIENCES SANTE ET HUMAINES S.E.C. (Sherbrooke, Canada).

"MCT formulations for improving cognitive functions" was invented by Bernard Cuenoud (Cully, Switzerland) and Stephen Cosgrave Cunnane (Sutton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods improve cognitive functioning, for example, at least one of episodic memory, executive function, or language skills; supporting memory and/or recall; providing energy and/or ketones to the brain; and/or preventing and/or treating mild cognitive impairment (MCI) in an individual. A compos...